Eqis Capital Management, Inc. Amphastar Pharmaceuticals, Inc. Transaction History

Eqis Capital Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$35.77 - $58.38 $128,271 - $209,350	3,586 New	3,586 $206,000
Q2 2022 Aug 08, 2022	SELL	$29.79 - $42.29 $254,883 - $361,833	-8,556 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$22.96 - $36.45 $196,445 - $311,866	8,556 New	8,556 $307,000
Q2 2018 Jul 27, 2018	SELL	$14.63 - $19.6 $310,243 - $415,637	-21,206 Closed	0 $0
Q1 2018 Apr 06, 2018	BUY	$17.23 - $20.35 $365,379 - $431,542	21,206 New	21,206 $398,000

280

36.7M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.64B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Eqis Capital Management, Inc. with notifications on news.